Evaira Vial Of 2Ml Solution For Injection
2ml Solution For Injection in VialMRP ₹23073.00
₹20315.70
12% OFF
Made by
CADILA HEALTHCARE LIMITED
Dosage
SOLUTION FOR INJECTION
Expiry
Product Summary
| Uses | Anticancer |
| Therapy | Anti-neoplastic |
| Side effects | Headache, dizziness, diarrhoea and vomiting |
| Salt Content | Eribulin Mesylate(0.5 Mg/Ml) |
Assurance
available
Regulated
Medical Description
Evaira solution for injection contains eribulin mesylate, a prescription anticancer medicine belonging to the microtubule inhibitor class. It is a synthetic derivative of a compound originally isolated from a marine sponge. It is supplied as a clear, colourless sterile solution in a single-use vial and is administered by a trained healthcare professional
Evaira solution for injection is used in adults with metastatic breast cancer who have previously received at least one chemotherapy regimen, including an anthracycline and a taxane, when further treatment is appropriate.
It is given as an intravenous injection by a trained healthcare professional. The dose is based on body surface area and may be adjusted according to blood counts, liver function, and overall health.
Uses
Contraindications
Side effects
- A low white blood cell count (neutropenia), which can increase the risk of serious infections
- Low red blood cell count (anaemia), causing tiredness and breathlessness
- Weakness and fatigue
- Hair loss (alopecia)
- Numbness, tingling, or burning in hands and feet (peripheral neuropathy)
- Nausea
- Constipation
- Headache and dizziness
- Diarrhoea and vomiting
- Fever (pyrexia)
- Muscle and joint pain
- Back and bone pain
- Loss of appetite and weight loss
- Cough and shortness of breath
- Difficulty sleeping (insomnia)
- Skin rash
- Swelling in the feet or legs
- Urinary tract infections
- Severe neutropenia and febrile neutropenia
- Severe peripheral neuropathy
- Changes in heart rhythm, including QT prolongation
- Serious hypersensitivity reactions
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You develop numbness, tingling, burning, or weakness in your hands or feet, as peripheral neuropathy may worsen and require dose adjustment or treatment interruption.
- You develop fever, chills, cough, or other signs of infection, as Evaira solution for injection can lower white blood cell counts.
- You have heart problems or take medicines affecting heart rhythm, as Evaira solution for injection may prolong the QT interval.
- You have liver or kidney impairment, as a dose reduction may be required.
- You are planning to have children, as Evaira solution for injection may affect fertility; discuss fertility preservation with your doctor.
- You are considering vaccination, as your immune response may be reduced during treatment.
Directions for Use
- Evaira solution for injection will be given in the hospital by your doctor or nurse.
- Do not self-inject this medicine. Follow any aftercare instructions given by the doctor or nurse.
Storage and disposal
- Store Evaira solution for injection according to the temperature and storage conditions specified on the product packaging or by the healthcare facility.
- Do not freeze.
- Keep out of reach of children and pets.
Quick Tips
- Report numbness, tingling, burning, or weakness in your hands or feet promptly, as peripheral neuropathy may worsen with treatment.
- Attend all scheduled blood tests before each dose to ensure your blood counts are safe for treatment.
- Seek medical attention for fever ≥38°C, chills, cough, or burning during urination, as these may indicate infection.
- Tell your doctor about any heart problems before treatment, as Evaira solution for injection may affect heart rhythm.
- Women who can become pregnant should use effective contraception during treatment and inform their doctor immediately if pregnancy occurs.
- Inform all your doctors, dentists, and emergency care providers that you are on Evaira solution for injection, as it affects your blood counts and immune system
Dosage
Overdose
Missed a Dose
- If you miss your scheduled Evaira solution for injection dose on Day 1 or Day 8, contact your doctor or treatment centre as soon as possible. Do not take or receive an extra dose to make up for the missed dose.
- Your doctor will decide whether to reschedule the dose or adjust the treatment cycle, depending on your blood counts and side effects.
How does this medicine work?
- Eribulin in Evaira solution for injection works by interfering with microtubules, tiny structures cancer cells need to divide and multiply. By blocking the growth of these structures, eribulin prevents cancer cells from dividing normally and can lead to cancer cell death.
- Studies have also shown that eribulin may reduce breast cancer cells' ability to move and invade nearby tissues. These additional effects have been observed in preclinical studies, and their clinical significance is not fully established.
- Preclinical studies have also observed effects on tumour blood flow and oxygenation; their relevance to clinical outcomes has not been established.
Interactions
Interactions with other medicines
- Evaira solution for injection has low potential for significant interactions through CYP enzymes.
- No clinically relevant interaction requiring dose adjustment has been identified with CYP3A4 or P-glycoprotein inhibitors.
- Use caution with QT-prolonging medicines, as they may increase the risk of heart-rhythm problems.
- Inform your doctor about all medicines, vitamins, supplements, and herbal products you take before starting treatment.
Interactions with food items
- No specific food interactions are known, as Evaira solution for injection is given as an intravenous injection and not taken by mouth
- Eating small, light, and frequent meals can help manage nausea, which is a common side effect
- Drinking enough water and fluids throughout the day supports overall health and kidney function during treatment
- Avoid alcohol during treatment, as it can worsen fatigue and nausea
Frequently Asked Questions (FAQs)
References:
- Central Drugs Standard Control Organisation (CDSCO). Drugs@CDSCO [Internet]. New Delhi: Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India; [cited 2026 Jul 7].
- Eisai Inc. HALAVEN™ (eribulin mesylate) injection: prescribing information [Internet]. Woodcliff Lake (NJ): Eisai Inc.; 2010 Nov [cited 2026 Jul 7].
- https://api.drreddys.com/product/eribulin-mesylate
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:EVAIRA
Manufacturer Name:CADILA HEALTHCARE LIMITED
Address:GUFIC BIOSCIENCE LIMITED - Plot No 58-67 , Secto B-1, Umariya-Dungariya, Tehsil-shahapu, Dist Jabalpur-MP,INdia 482003.
Country of Origin:India
Vendor Details
Fulfillment Information: Evaira 0.5 MG/ML Solution For Injection (2) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.




















